1-4 of 4
Abid Jamil
Close
Sort by
Journal Articles

Discovery of Mutated MUC3A Gene As a Novel Transcription Factor Exclusively Associated with Accelerated Phase Chronic Myeloid Leukemia: Hunt for Common Biomarker of Fatal CML Progression

Sameen Shahid, Muhammad Sabar, Abid Jamil, Muhammad Abbas Khokar, Muhammad Absar, Mudassar Iqbal, Masood A. Shammas, Giuseppe Saglio, Sulman Basit, Sibtain Afzal, Khushnooda Ramzan, Aamer Aleem, Amer Mahmood, Nawaf Alanzazi, Muhammad Javed Asif, Mahmood Rasool, Ahmad Khalid, Zafar Iqbal
Journal: Blood
Blood (2023) 142 (Supplement 1): 7429.
https://doi.org/10.1182/blood-2023-185547
Published: 2023
Journal Articles

Next-Generation Sequencing Identifies a Previously Uncharacterized Gene ANKRD36 As a Common Biomarker for Blast Crisis Chronic Myeloid Leukemia: Molecular and Protein Bio-Modeling Studies

Zafar Iqbal, MPhil,PhD, Muhammad Absar, BSc, MSc, PhD, Abid Jamil, MDPhD, Tanveer Akhtar, PhD, Salman Basit, PhD, Sibtain Afzal, Khushnooda Ramzan, Kulsoom Qureshi, Muhammad Farooq Sabar, PhD, Muhammad Arshad, Aamer Aleem, MBBS, FRCP, FRCPath, Ullah Anhar, Zeenat Mirza, PhD, Sajjad Karim, Naila Batool Khalid, Mahmood Rasool, Muhammad Asif, PhD, Mujib Ullah, PhD, Ahmad M Khalid, PhD, Amer Mahmood, PhD, Nawaf Alanazi, MBBS FRCPC
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-143068
Published: 2020
Journal Articles

Disovery of Novel Mutations Exclusively Shared By Accelerated and Blast Crisis Phase CML Patients Using Whole Exome Sequencing:Implication in Hunt for Common Biomarker /Drug Target of CML Progression

Zafar Iqbal, MPhil PhD, Salman Basit, PhD, Abid Jamil, MDPhD, Muhammad Absar, Anhar Ullah, MS, Sibtain Afzal, Aamer Mahmood, PhD, Khushnooda Ramzan, PhD, Aamir Aleem, Jamil Amjad Hashmi, Noor Rehman, Khalid Aljamaan, Saleh Aloraibi, Giuseppe Saglio, MD PhD, Nawaf Alanazi, Mudassar Iqbal, MDMS, Tanveer Akhtar
Journal: Blood
Blood (2017) 130 (Supplement 1): 2886.
https://doi.org/10.1182/blood.V130.Suppl_1.2886.2886
Published: 2017
Journal Articles

Presence of Prior-to-Treatment BCR-ABL Mutations In CD34+CD38- Stem Cells of Newly Diagnosed Chronic Phase CML Patients and Their Correlation with Imatinib Resistance: Implications of Cancer Pharmacogenomics and Pre-Therapeutic Genetic Testing In Personalized Treatment of BCR-ABL+ Leukemia

Zafar Iqbal, BSc, MSc, MPhil, PhD, Mudassar Iqbal, MD, Tanveer Akhtar, MSc, PhD, Mubashar Iqbal Naqvi, BS(CS), Ammara H Tahir, MBBS, Tariq Jameel Gill, MBBS, Muhammad Naeem Abbas, MLT, Abid Jamil, MBBS, PhD, Abid Sohail Taj, MBBS, PhD, Dr Abd-Al-Qayyum, MD, Najeeb ur-Rehman, BS, (Engg), Muhammad Ferhan, MSc, MPhil, Ijaz Hussain Shah, MBBS, FCPS, Muhammad Khalid, MBBS, FCPS, Weng Xian Qin, BSc(MLT), MS, Ahmad Mukhtar Khalid, MSc, PhD, Mahwish Khan, Aamer Aleem, MD, Shahid Mahmood Baig, MPhil, PhD
Journal: Blood
Blood (2010) 116 (21): 2278.
https://doi.org/10.1182/blood.V116.21.2278.2278
Published: 2010